Adolescent Nutrition in Girls in Burkina Faso and Ethiopia
NCT ID: NCT06444555
Last Updated: 2024-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
400 participants
INTERVENTIONAL
2024-05-28
2024-07-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Joint Infant and Young Child Nutrition Program and Malnutrition Prevention
NCT02136966
Effect of a Fortified Balanced Energy-Protein Supplement on Birth Outcome and Child Growth in Houndé District, Burkina Faso.
NCT03533712
School-Based Assessment of Micronutrient Interventions in Adolescents in Burkina Faso
NCT04657640
The Effect of Integrated Prevention and Treatment on Child Malnutrition and Health in Burkina Faso: a Cluster Randomized Intervention Study
NCT02245152
Effectiveness and Cost-Effectiveness of Four Formulations of Food Supplements for the Prevention of Wasting and Stunting in Burkina Faso
NCT02071563
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study aims to assess the adequacy, acceptability, and feasibility of implementing nutritional supplementations to fill nutrient gaps in adolescent girls in resource-limited settings. A trial will specifically:
1. assess the short-term acceptability of BEP and MMN supplements
2. assess how nutrition supplements increase nutrient adequacy of diets adolescent girls in resources-limited settings;
Using a qualitative component, the study explores the food agency of adolescents and the most effective delivery platform to reach vulnerable adolescent girls cost-effectively. The overall aim is to guide policies and programs on new formulations of nutritional supplements for adolescent girls in resource-limited settings.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Balanced Energy Protein Supplement
Fortified lipid-based nutrient supplement
BEP supplement
The BEP supplement used in Burkina Faso is a fortified medium-quantity lipid-based nutrient supplement called Plumpy'Doz. The product is a peanut and milk-based ready-to-use nutritional formulation produced by Nutriset. A peanut-based BEP formulation with a trademark Plumpy'Sup produced by Hilina Enriched Foods PLC will be used in Ethiopia.
Multiple Micronutrient Supplement
The United Nations International Multiple Micronutrient Antenatal Preparation (UNIMMAP).
Multiple Micronutrient supplement
The MMN formulation is based on the United Nations International Multiple Micronutrient Antenatal Preparation (UNIMMAP). The formulation contains 15 minerals and vitamins and is administered as a tablet.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BEP supplement
The BEP supplement used in Burkina Faso is a fortified medium-quantity lipid-based nutrient supplement called Plumpy'Doz. The product is a peanut and milk-based ready-to-use nutritional formulation produced by Nutriset. A peanut-based BEP formulation with a trademark Plumpy'Sup produced by Hilina Enriched Foods PLC will be used in Ethiopia.
Multiple Micronutrient supplement
The MMN formulation is based on the United Nations International Multiple Micronutrient Antenatal Preparation (UNIMMAP). The formulation contains 15 minerals and vitamins and is administered as a tablet.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Without any known chronic illness or acute illness affecting appetite
* Permanent residents of the study area
Exclusion Criteria
* Eating disorders or dietary restrictions
15 Years
19 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Addis Continental Institute of Public Health
OTHER
Institut de Recherche en Sciences de la Sante, Burkina Faso
OTHER_GOV
Bill and Melinda Gates Foundation
OTHER
AfricSanté, Burkina Faso
UNKNOWN
University Ghent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yemane Berhane, Prof
Role: PRINCIPAL_INVESTIGATOR
Addis Continental Institute of Public Health
Firehiwot Workneh, dr.
Role: STUDY_DIRECTOR
Addis Continental Institute of Public Health
Moustapha Drabo, Dr
Role: STUDY_DIRECTOR
University Ghent
Carl Lachat, Prof
Role: STUDY_CHAIR
University Ghent
Laeticia Céline Toé, MD
Role: PRINCIPAL_INVESTIGATOR
Institute de Recherche en Sciences de la Santé, Bobo Dioulasso
Hans De Steur, Prof
Role: PRINCIPAL_INVESTIGATOR
University Ghent
Alemayehu Alemayehu, Dr
Role: PRINCIPAL_INVESTIGATOR
University Ghent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Agence de Formation, de Recherche et d'Expertise en Santé pour l'Afrique (AFRICSanté)
Bobo-Dioulasso, , Burkina Faso
Addis Continental Institute of Public Health
Addis Ababa, , Ethiopia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ONZ-2024-0038
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.